Literature DB >> 26819509

Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Carlo Palazzi1, Emilio D'Amico1, Salvatore D'Angelo1, Michele Gilio1, Ignazio Olivieri1.   

Abstract

Hepatitis C virus (HCV) is a hepato- and lymphotropic agent that is able to induce several autoimmune rheumatic disorders: vasculitis, sicca syndrome, arthralgias/arthritis and fibromyalgia. The severity of clinical manifestations is variable and sometimes life-threatening. HCV infection can mimic many primitive rheumatic diseases, therefore, it is mandatory to distinguish HCV-related manifestations from primitive ones because the prognosis and therapeutic strategies can be fairly dissimilar. The new direct-acting antivirals drugs can help to avoid the well-known risks of worsening or new onset of autoimmune diseases during the traditional interferon-based therapies.

Entities:  

Keywords:  Arthritis; Cryoglobulinemia; Diagnosis; Hepatitis C; Hepatitis C virus; Rheumatic; Sicca syndrome; Vasculitis

Mesh:

Substances:

Year:  2016        PMID: 26819509      PMCID: PMC4721975          DOI: 10.3748/wjg.v22.i4.1405

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  74 in total

1.  Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection.

Authors:  Eric Toussirot; Gaëlle Le Huédé; Christiane Mougin; Jean-Charles Balblanc; Dominique Bettinger; Daniel Wendling
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

Review 2.  From non-A, non-B hepatitis to hepatitis C virus cure.

Authors:  Jean-Michel Pawlotsky; Jordan J Feld; Stefan Zeuzem; Jay H Hoofnagle
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 3.  Extrahepatic manifestations of chronic hepatitis C virus infection.

Authors:  Patrice Cacoub; Laura Gragnani; Cloe Comarmond; Anna Linda Zignego
Journal:  Dig Liver Dis       Date:  2014-11-08       Impact factor: 4.088

4.  In situ detection of hepatitis C virus RNA in salivary glands.

Authors:  J J Arrieta; E Rodríguez-Iñigo; N Ortiz-Movilla; J Bartolomé; M Pardo; F Manzarbeitia; H Oliva; D M Macías; V Carreño
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

5.  Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome.

Authors:  C A Scott; C Avellini; L Desinan; M Pirisi; G F Ferraccioli; P Bardus; C Fabris; L Casatta; E Bartoli; C A Beltrami
Journal:  Histopathology       Date:  1997-01       Impact factor: 5.087

6.  True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.

Authors:  Salvatore De Vita; Rosaria Damato; Ginevra De Marchi; Stefania Sacco; Gianfranco Ferraccioli
Journal:  Isr Med Assoc J       Date:  2002-12       Impact factor: 0.892

7.  The clinical and morphologic spectrum of renal cryoglobulinemia.

Authors:  Srinivasan Beddhu; Sheldon Bastacky; John P Johnson
Journal:  Medicine (Baltimore)       Date:  2002-09       Impact factor: 1.889

8.  Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.

Authors:  D Sène; P Ghillani-Dalbin; N Limal; V Thibault; T van Boekel; J-C Piette; P Cacoub
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

9.  Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.

Authors:  Benjamin Terrier; Alexandre Karras; Philippe Cluzel; Jean-Philippe Collet; Damien Sène; David Saadoun; Patrice Cacoub
Journal:  Am J Cardiol       Date:  2012-10-30       Impact factor: 2.778

10.  Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis.

Authors:  A Riccio; L Postiglione; P La Dogana; A Spanò; C Marzocchella; G Tarantino
Journal:  J Biol Regul Homeost Agents       Date:  2008 Jan-Mar       Impact factor: 1.711

View more
  5 in total

1.  Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.

Authors:  Isabela Siloşi; Lidia Boldeanu; Viorel Biciuşcă; Maria Bogdan; Carmen Avramescu; Citto Taisescu; Vlad Padureanu; Mihail Virgil Boldeanu; Anica Dricu; Cristian Adrian Siloşi
Journal:  Int J Mol Sci       Date:  2017-06-19       Impact factor: 5.923

Review 2.  Maternal natural killer cells at the intersection between reproduction and mucosal immunity.

Authors:  Evgeniya V Shmeleva; Francesco Colucci
Journal:  Mucosal Immunol       Date:  2021-04-26       Impact factor: 7.313

3.  Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors: A cross-sectional study.

Authors:  Ayumi Hida; Misa Imaizumi; Benjamin French; Waka Ohishi; Daisuke Haruta; Katsumi Eguchi; Hideki Nakamura; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

4.  A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia.

Authors:  Kairi Mansberg; Karin Kull; Riina Salupere; Tiina Prükk; Benno Margus; Toomas Kariis; Triin Remmel; Külliki Suurmaa; Kristi Ott; Krista Jaago; Jelena Šmidt
Journal:  Medicina (Kaunas)       Date:  2018-03-25       Impact factor: 2.430

5.  Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database.

Authors:  Chien-Hsueh Tung; Ning-Sheng Lai; Chung-Yi Li; Shiang-Jiun Tsai; Yen-Chun Chen; Yi-Chun Chen
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.